Reviva Pharmaceuticals Holdings Inc. Warrants (25/12/2025) RVPHW 深 滬
等待開盤 10-04 09:30:00 美东时间
0.0479
-0.001
-1.24%
華盛通- 最 高0.0543
- 今 開0.0535
- 成交量 7.46万股
- 最 低 0.0479
- 昨 收 0.0485
- 總市值 44.22万
- 52周最高 0.78
- 市盈率 靜 --
- 換手率 0.00%
- 52周最低 0.0226
- 委 比 -96.44%
- 總股本 923.17万
- 歷史最高 3.00
- 量 比 0.84
- 振 幅 13.20%
- 歷史最低 0.0226
- 每 手 1
- 風險率 0.43%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Chardan Capital Initiates Coverage On Reviva Pharmaceuticals with Buy Rating, Announces Price Target of $2
Chardan Capital analyst Rudy Li initiates coverage on Reviva Pharmaceuticals (NASDAQ: RVPH) with a Buy rating and announces Price Target of $2.
09-29 19:22
Reviva Pharmaceuticals Amends Bylaws to Ease Quorum
Reviva Pharmaceuticals Holdings ( ($RVPH) ) has issued an update. On September ...
09-27 05:29
Reviva Pharmaceuticals Announces Public Offering to Raise Funds
Reviva Pharmaceuticals Holdings ( ($RVPH) ) has shared an announcement. On Sept...
09-20 05:44
Top 3 Health Care Stocks That May Explode In September
The most oversold stocks in the health care sector presents an opportunity to b...
09-19 19:01
Why FedEx Shares Are Trading Higher By 5%; Here Are 20 Stocks Moving Premarket
Shares of FedEx Corporation (NYSE:FDX) rose sharply in pre-market trading after...
09-19 17:25
Reviva Pharmaceuticals announces proposed public offering
Reviva Pharmaceuticals Holdings (NASDAQ:RVPH) on Thursday said it intends to offer shares of its common stock and warrants to purchase shares of common stock in a public offering. All of the securitie...
09-19 04:18
Benchmark Maintains Speculative Buy on Reviva Pharmaceuticals, Lowers Price Target to $7
Benchmark analyst Bruce D. Jackson maintains Reviva Pharmaceuticals (NASDAQ:RVPH) with a Speculative Buy and lowers the price target from $14 to $7.
09-15 21:01
Reviva Pharmaceuticals Advances Schizophrenia Treatment
Reviva Pharmaceuticals Holdings, Inc. ( ($RVPH) ) has released its Q2 earnings....
08-19 12:11
D. Boral Capital Maintains Buy on Reviva Pharmaceuticals, Maintains $3 Price Target
D. Boral Capital analyst Jason Kolbert maintains Reviva Pharmaceuticals (NASDAQ:RVPH) with a Buy and maintains $3 price target.
08-18 19:27
Reviva Pharmaceuticals Holdings shares are trading higher after the company reportedbetter-than-expected Q2 EPS results.
Reviva Pharmaceuticals Holdings shares are trading higher after the company rep...
08-15 22:54
